| # | Drug | Count |
|---|---|---|
| 0 | APIXABAN | 4 |
| 1 | NINTEDANIB | 2 |
| 2 | CARTEOLOL HYDROCHLORIDE | 1 |
| 3 | EMICIZUMAB | 1 |
| 4 | LATANOPROST | 1 |
| 5 | ORAL SEMAGLUTIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CARTEOLOL HYDROCHLORIDE | 1 | 0.0030 |
| 1 | EMICIZUMAB | 1 | 0.0001 |
| 2 | NINTEDANIB | 2 | 0.0001 |
| 3 | APIXABAN | 4 | 0.0001 |
| 4 | LATANOPROST | 1 | 0.0000 |
| 5 | ORAL SEMAGLUTIDE | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 4 |
| 1 | GLP-1 Receptor Agonist [EPC] | 1 |
| 2 | Prostaglandin Analog [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 4 | 0.0000 |
| 1 | Prostaglandin Analog [EPC] | 1 | 0.0000 |
| 2 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |